Physician

Peter D Nicholas, M.D.

According to 2025 Medicare claims, Peter Nicholas, M.D. (NPI: 1730185505) practices rheumatology in the Reading, PA market, with the plurality of this provider's patient population coming from Berks, PA. This provider's primary affiliated billing organization is ARTHRITIS AND OSTEOPOROSIS CENTER, INC. (NPI: 1194786491; TIN: 231949591) and primary practice location at 19610-3359.

Nicholas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 523 traditional Medicare patients, billed 72,446 HCPCS/CPT codes, and received $930,566 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,118 prescription claims across 453 beneficiaries totaling $1,399,190 in drug costs, led by Stelara (Ustekinumab). 2022 DME data shows 25 claims. Open Payments data shows 42 records totaling $1,049. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $661,704 to $930,566. Similarly, Part D prescription costs have moved sharply higher in recent years, from $610,244 to $1,399,190. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	584	24,985	$661,704
2016	635	42,362	$814,296
2017	621	43,499	$852,000
2018	635	53,877	$1,051,841
2019	699	76,404	$1,293,665
2020	639	83,028	$1,395,645
2021	668	94,718	$1,521,096
2022	648	102,683	$1,305,450
2023	673	102,942	$1,301,300
2024	523	72,446	$930,566

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	450	3,357	$610,244
2016	465	3,544	$749,116
2017	470	3,453	$768,125
2018	517	3,455	$750,560
2019	503	3,252	$571,973
2020	463	3,164	$596,419
2021	460	3,094	$600,994
2022	476	3,180	$535,714
2023	481	3,222	$1,123,124
2024	453	3,118	$1,399,190

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	22	$737
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	11	$119
2019	N/R	N/R	N/R
2020	N/R	11	$404
2021	N/R	11	$360
2022	N/R	25	$1,785
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	348	681	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	229	363	$62
J0897	Injection, denosumab, 1 mg	150	13,200	$20
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	131	167	$12
96372	Injection of drug or substance under skin or into muscle	162	362	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	17	1,428	$457,249
Xeljanz Xr	Tofacitinib Citrate	32	960	$180,733
Enbrel Sureclick	Etanercept	24	672	$175,747
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	13	364	$127,392
Cosentyx Sensoready (2 Pens)	Secukinumab	17	476	$127,146

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	42	$1,049	UCB, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Peter D. Nicholas, M.D.?

Tedicare shows public-source Medicare data for Peter D. Nicholas, M.D. (NPI 1730185505), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter D. Nicholas, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Peter D. Nicholas, M.D.?

Peter D. Nicholas, M.D. is linked to ARTHRITIS AND OSTEOPOROSIS CENTER, INC. (billing NPI 1194786491) in the available physician profile data.

Does Peter D. Nicholas, M.D. have Open Payments data?

Peter D. Nicholas, M.D. has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.